Results 231 to 240 of about 17,128 (260)

Reframing obesity and MASLD

Nature Reviews Gastroenterology & Hepatology
openaire   +2 more sources

Introduction of MASLD

Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, Mohammed Eslam   +2 more
openaire   +1 more source

IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis

Cell Metabolism
Michael Karin, Mojgan Hosseini, Santosh Lamichhane   +2 more
exaly  

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

Metabolism: Clinical and Experimental
Michael Roden, Sabine Kahl
exaly  

MASLD: To screen or not to screen—That is the question

Hepatology
Jack W. Sample, Sumera I. Ilyas
openaire   +2 more sources

Lean MASLD: are overweight or obese people with MASLD ‘protected’ from CVD mortality?

Current Problems in Cardiology
Luan C V Lima, Marcio J M Amaral, Guilherme F Barbosa, Pedro Barbosa, Matheus Souza   +4 more
openaire   +2 more sources

Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment

Trends in Pharmacological Sciences
Prakash Ramachandran, Ruchi Bansal
exaly  

MASLD as a non-communicable disease

Nature Reviews Gastroenterology & Hepatology
Silvia Sookoian, Carlos J. Pirola, Arun J. Sanyal   +2 more
openaire   +2 more sources

Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

International Journal of Molecular Sciences
Nicolas Ortiz-López, Máximo Jose Cattaneo Buteler, Martin Gotteland   +2 more
exaly  

Essentiality of SLC7A11-mediated nonessential amino acids in MASLD

Science Bulletin
Junxia Min, Fudi Wang, Enjun Xie
exaly